Iñigo Narvaiza

3.5k citations
27 papers · 2.4k indexed · h-index 20
Topics
Virus-based gene therapy research (13 papers)CAR-T cell therapy research (6 papers)CRISPR and Genetic Engineering (6 papers)

In The Last Decade

Iñigo Narvaiza

27 papers receiving 2.4k citations

Peers

Iñigo Narvaiza
Comparison fields: 5 of 106
  • Molecular Biology 1.6k
  • Genetics 525
  • Immunology 518
  • Plant Science 413
  • Oncology 374
Replace Petra Neddermann with:
Petra Neddermann Italy
Benoit Coulombe Canada
G E Mark United States
S Kawai Japan
Sandra A. Jablonski United States
Evangelos Christodoulou United Kingdom
Michel Strubin Switzerland
Mitsuhiro Yanagida Japan
Gwénaël Rabut France
J L Corden United States
Iñigo Narvaiza relative to Petra Neddermann Italy Petra Neddermann's profile →
Citations per field
00.5×3.3×
Petra Neddermann · 1×
Citations per year

Countries citing papers authored by Iñigo Narvaiza

Since Specialization
Citations

This map shows the geographic impact of Iñigo Narvaiza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iñigo Narvaiza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iñigo Narvaiza more than expected).

Fields of papers citing papers by Iñigo Narvaiza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iñigo Narvaiza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iñigo Narvaiza. The network helps show where Iñigo Narvaiza may publish in the future.

Co-authorship network of co-authors of Iñigo Narvaiza

This figure shows the co-authorship network connecting the top 25 collaborators of Iñigo Narvaiza. A scholar is included among the top collaborators of Iñigo Narvaiza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iñigo Narvaiza. Iñigo Narvaiza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 313
3 15
4 30
5 223
6 161
7 169
8 13
9 68
10 115
11 6
12 321
13 30
14 133
15 43
16 2
17 19
18
Gene therapy of primary and metastatic liver tumors.
1
19 5
20 50

About Iñigo Narvaiza

Iñigo Narvaiza is a scholar working on Genetics, Virology and Biotechnology, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), CAR-T cell therapy research (6 papers) and CRISPR and Genetic Engineering (6 papers). The work is most often cited by research in Virology (320 citations), Immunology (518 citations) and Molecular Biology (1.6k citations). Iñigo Narvaiza has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Matthew D. Weitzman, Jesús Prìeto, Ignacio Melero, Fred H. Gage, Cheng Qian, Guillermo Mazzolini, Nathaniel R. Landau, Sébastien Landry, Mikel Zaratiegui and Miguel Barajas. Their work appears in journals such as Nature, Cell and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026